Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct 15:221:772-6.
doi: 10.1016/j.ijcard.2016.07.127. Epub 2016 Jul 9.

Predicting procedure successful rate and 1-year patency after endovascular recanalization for chronic carotid artery occlusion by CT angiography

Affiliations

Predicting procedure successful rate and 1-year patency after endovascular recanalization for chronic carotid artery occlusion by CT angiography

Chung-Wei Lee et al. Int J Cardiol. .

Abstract

Background: Proper patient selection criteria for treatment of carotid chronic total occlusion (CTO) are unclear. This study was designed to predict procedure successful rate and 1-year patency after carotid artery stenting (CAS) for carotid CTO using pre-procedural CTA.

Methods: Patients with CTO detected on CTA who underwent recanalization within 3months were divided into those with occlusions at (or distal to) the clinoid segment of the internal carotid artery (group A) and those with occlusions proximal to the clinoid segment (group B) and outcomes were compared between groups.

Results: Technical success rates, major complications, and re-occlusions within 1-year were 52%, 22%, 91% in group A (N=23), and 89%, 0%, 0% in group B (N=19), respectively. Diabetes was more frequent in group A (43%) compared with group B (11%).

Conclusion: CTA may play a role in predicting successful rate and 1-year patency for endovascular recanalization in carotid CTO.

Keywords: CT angiography; Carotid artery stenting; Chronic carotid artery occlusion; Chronic total occlusion; Endovascular recanalization.

PubMed Disclaimer

Comment in

LinkOut - more resources